Voyager Therapeutics (NASDAQ:VYGR) just reported results for the second quarter of 2024.
- Voyager Therapeutics reported earnings per share of -18 cents. This was above the analyst estimate for EPS of -41 cents.
- The company reported revenue of $29.58 million.
- This was 212.66% better than the analyst estimate for revenue of $9.46 million.